Updates are available Correction dated 2025-11-17
Click to view Correction: https://doi.org/10.1038/s41556-025-01836-1
-
Authors
De Jesus, Dario F. https://orcid.org/0000-0001-8826-9095
Zhang, Zijie
Brown, Natalie K.
Li, Xiaolu https://orcid.org/0000-0002-9845-1584
Xiao, Ling
Hu, Jiang
Gaffrey, Matthew J.
Fogarty, Garrett
Kahraman, Sevim
Wei, Jiangbo https://orcid.org/0000-0003-2691-6490
Basile, Giorgio
Rana, Tariq M.
Mathews, Clayton
Powers, Alvin C.
Parent, Audrey V.
Atkinson, Mark A.
Dhe-Paganon, Sirano
Eizirik, Decio L. https://orcid.org/0000-0003-2453-5889
Qian, Wei-Jun https://orcid.org/0000-0002-5393-2827
He, Chuan https://orcid.org/0000-0003-4319-7424
Kulkarni, Rohit N. https://orcid.org/0000-0001-5029-6119
-
Funding
Funding for this research was provided by:
American Diabetes Association (7-21-PDF-140)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (K99 DK135927)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (UC4 DK116278)
DOE | Advanced Research Projects Agency - Energy (DE-AC05-76RL0 1830)
U.S. Department of Health & Human Services | National Institutes of Health (RM1 HG008935)
- License Information
-
More Information
Article History
Received: 16 March 2023
Accepted: 26 January 2024
First Online: 26 February 2024
Change Date: 17 November 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41556-025-01836-1
Competing interests
: R.N.K is on the scientific advisory board of Novo Nordisk, Biomea and REDD. C.H. is a scientific founder and a member of the scientific advisory board of Accent Therapeutics. The remaining authors have no conflicts of interest.
